July 29, 2020
Toru Terashima, Head of the Reliability Assurance Division, Sawai Pharmaceutical Since last year, Japan has seen a number of stock-outs and shortages of generic drugs attributable to API supply disruptions overseas. The issue has now been further compounded by the...read more